Sipp Industries, Inc. announced a distribution agreement with SinuSave for its SinuSave CBD Nasal Spray products. Sinu save CBD Nasal Spray, offering a range of patented CBD nasal spray products in 500mg and 1000mg strengths, is poised to transform the wellness industry. Through this strategic partnership, SIPP Industries solidifies its commitment to offering cutting-edge, premium-grade products to consumers seeking innovative health solutions.

SinuSave CBD is proven to be 'bacteriostatic' and 'bactericidal.' The spray consists of CBD combined with a patented composition of nine essential oils. CBD may provide relief from pain and symptoms associated withergies, colds, sinusitis, and discomfort resulting from air pollution.

SinuSave cannabis is the only all-natural drug-free patented product specifically designed for daily nasal hygiene of its type. SinuSaveC Nasal Spray offers a unique fusion of innovation and wellness. It leverages the benefits of Original SinuSave®?, which has been supporting nasal health since 2017, in a novel application of cannabidiol.

Its proprietary formulation demonstrates the dedication of both SIPP Industries and SinuSave®? to pioneering accessible, high-quality products that cater to the evolving needs of consumers. The global nasal spray market was valued at $24.5 billion in 2022 and expect to grow at a CAGR of 6.7% according to Verified Market Research.

SIPP Industries will be responsible for the sales, marketing, and distribution of the products. The product line will soon be available for purchase both online and through retail stores. Additionally, the Company is actively pursuing international distribution opportunities for SinuSave.